Literature DB >> 8815793

Determinants of maximal oxygen transport and utilization.

P D Wagner1.   

Abstract

Maximal VO2 (VO2max) has mostly been the province of exercise physiologists wishing to provide a measure of athletic potential or to characterize subjects in exercise-related research. It is also used clinically to determine a patient's exercise capacity. More recently, it has been recognized that the study of VO2max can provide fundamental insight into O2 transport at all points between inspired air and muscle mitochondria. This review focuses on understanding how VO2max is set and concludes that the more athletic one is, the more VO2max is sensitive to O2 transport conductances in the lungs, circulation, and skeletal muscle. These transport conductances form an integrated system, all components interacting to define VO2max. A particularly important component is diffusive conductance in muscle. This appears to be abnormal in chronic conditions such as obstructive pulmonary disease and heart and renal failure and may well explain why correction of central cardiovascular defects in O2 transport in such patients fails to restore exercise capacity.

Entities:  

Mesh:

Year:  1996        PMID: 8815793     DOI: 10.1146/annurev.ph.58.030196.000321

Source DB:  PubMed          Journal:  Annu Rev Physiol        ISSN: 0066-4278            Impact factor:   19.318


  113 in total

1.  The quantitative genetics of maximal and basal rates of oxygen consumption in mice.

Authors:  M R Dohm; J P Hayes; T Garland
Journal:  Genetics       Date:  2001-09       Impact factor: 4.562

2.  Muscle intracellular oxygenation during exercise: optimization for oxygen transport, metabolism, and adaptive change.

Authors:  Peter D Wagner
Journal:  Eur J Appl Physiol       Date:  2011-04-22       Impact factor: 3.078

3.  Soccer specific aerobic endurance training.

Authors:  Jan Hoff; U Wisløff; L C Engen; O J Kemi; J Helgerud
Journal:  Br J Sports Med       Date:  2002-06       Impact factor: 13.800

Review 4.  A comparative meta-analysis of maximal aerobic metabolism of vertebrates: implications for respiratory and cardiovascular limits to gas exchange.

Authors:  Stanley S Hillman; Thomas V Hancock; Michael S Hedrick
Journal:  J Comp Physiol B       Date:  2012-07-10       Impact factor: 2.200

5.  Patterns of senescence in human cardiovascular fitness: VO2 max in subsistence and industrialized populations.

Authors:  Anne C Pisor; Michael Gurven; Aaron D Blackwell; Hillard Kaplan; Gandhi Yetish
Journal:  Am J Hum Biol       Date:  2013-09-10       Impact factor: 1.937

6.  Physiological adaptations to soccer specific endurance training in professional youth soccer players.

Authors:  K McMillan; J Helgerud; R Macdonald; J Hoff
Journal:  Br J Sports Med       Date:  2005-05       Impact factor: 13.800

7.  Age is no barrier to muscle structural, biochemical and angiogenic adaptations to training up to 24 months in female rats.

Authors:  H B Rossiter; R A Howlett; H H Holcombe; P L Entin; H E Wagner; P D Wagner
Journal:  J Physiol       Date:  2005-04-21       Impact factor: 5.182

8.  Exploring the underlying biology of intrinsic cardiorespiratory fitness through integrative analysis of genomic variants and muscle gene expression profiling.

Authors:  Sujoy Ghosh; Monalisa Hota; Xiaoran Chai; Jencee Kiranya; Palash Ghosh; Zihong He; Jonathan J Ruiz-Ramie; Mark A Sarzynski; Claude Bouchard
Journal:  J Appl Physiol (1985)       Date:  2019-01-03

Review 9.  Determinants of exercise intolerance in patients with heart failure and reduced or preserved ejection fraction.

Authors:  Mark J Haykowsky; Corey R Tomczak; Jessica M Scott; D Ian Paterson; Dalane W Kitzman
Journal:  J Appl Physiol (1985)       Date:  2015-04-24

10.  (-)-Epicatechin is associated with increased angiogenic and mitochondrial signalling in the hindlimb of rats selectively bred for innate low running capacity.

Authors:  Maik Hüttemann; Icksoo Lee; Guy A Perkins; Steven L Britton; Lauren G Koch; Moh H Malek
Journal:  Clin Sci (Lond)       Date:  2013-06       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.